{"symbol":"REGN","fiscalQuarter":"Q1-2008","reportDate":"2008-04-30","reportTime":"BMO","status":"reported","company":{"name":"Regeneron Pharmaceuticals, Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/REGN/earnings/Q1-2008","postBrief":{"headline":"Regeneron Pharmaceuticals Misses on EPS, Stock Down 1.9%","keyNumbers":[{"metric":"EPS","actual":"$-0.15","expected":"N/A","surprise":"N/A"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management did not provide specific revenue guidance for the upcoming quarters.","The company remains focused on its long-term growth strategy despite the current challenges."],"summary":"Management expressed caution regarding the current market conditions. They emphasized their commitment to innovation and long-term goals."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"Regeneron's earnings report showed a loss per share, which contributed to a 1.9% drop in stock price. The lack of revenue data and guidance may raise concerns among investors about the company's short-term performance. Management's cautious tone suggests they are navigating through challenges but remain focused on future growth.","metaDescription":"Regeneron Pharmaceuticals (REGN) Q1 2008 earnings: EPS missed. Stock down 1.9%. Full breakdown."}}